S
Sigachi Industries Ltd
NSE:SIGACHI
Sigachi Industries Ltd
NSE:SIGACHI
Price:
20.73
INR
8.03%
Market Closed
Market Cap:
₹7.9B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
S
|
Sigachi Industries Ltd
NSE:SIGACHI
|
IN |
|
A
|
Avi Ltd
JSE:AVI
|
ZA |
|
RMR Group Inc
NASDAQ:RMR
|
US |
|
Z
|
Zardoya Otis SA
F:ZDO
|
ES |
|
Argo Group Ltd
LSE:ARGO
|
IM |
|
H
|
Higen RNM Co Ltd
KOSDAQ:160190
|
KR |
|
Rational AG
XETRA:RAA
|
DE |
|
V
|
VenueG Co Ltd
KOSDAQ:019010
|
KR |
|
Aston Martin Lagonda Global Holdings PLC
LSE:AML
|
UK |
|
Gujarat Themis Biosyn Ltd
BSE:506879
|
IN |
Multiples-Based Value
The Multiples-Based Value of one SIGACHI stock under the Base Case scenario is hidden INR. Compared to the current market price of 20.73 INR, Sigachi Industries Ltd is hidden .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
SIGACHI Multiples-Based Value
LOCKED
Multiples Across Competitors
SIGACHI Competitors Multiples
Sigachi Industries Ltd Competitors
Sigachi Industries Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| IN |
S
|
Sigachi Industries Ltd
NSE:SIGACHI
|
7.3B INR | 1.6 | -10.4 | 12.2 | 16.8 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
900.7B USD | 13.8 | 43.6 | 29.4 | 31.4 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
581B USD | 6.2 | 21.7 | 15.1 | 18.5 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
236B GBP | 5.3 | 30.6 | 16.9 | 23.8 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4 | 19.2 | 11.4 | 12.8 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
304.8B USD | 4.7 | 16.7 | 10.3 | 12.6 | |
| CH |
|
Novartis AG
SIX:NOVN
|
229.9B CHF | 5.2 | 20.8 | 12.9 | 16.6 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD | 105.4 | -83.6 | 386.8 | 970 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK | 3.5 | 10.5 | 7.8 | 9.1 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
156.2B USD | 2.5 | 20.1 | 7.7 | 10.3 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
119.2B USD | 2.5 | 16.9 | 7.1 | 8.8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
